Looking Ahead: Innovative Treatments and Precision Approaches in Prostate Cancer

A regional roundtable discussion, moderated by Brian Myre, MD, Brian Moran Cancer Institute, examined the evolving landscape of prostate cancer management—from localized disease and salvage strategies to metastatic settings and future innovations in precision therapy. Dr. Myre was joined by other practitioners in the greater Chicago area, including Andrew Wiele, DO, Endeavor Health Cancer Institute; Ranko Miocinovic, MD, Brian Moran Cancer Institute; Amit R. Patel, MD, Brian Moran Cancer Institute; Ashley Ross, MD, PhD, Northwestern Feinberg School of Medicine; and Alan Wan, DO, Brian Moran Cancer Center. In the final segment, they conclude with a forward-looking discussion on emerging prostate cancer therapies, including cellular therapies, frontline radioligand strategies, and organ-sparing approaches. They also highlight ongoing efforts to improve early diagnosis, minimize treatment morbidity, and explore innovative focal and immunotherapy approaches to prevent disease progression.